secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001628280-24-040137
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology Q1 revenue $14.1M, net income $1.3M, adjusted EBITDA $2.0M
-----------------------------------------------------------------------------

- Revenue rose 12% YoY to $14.1M; net income of $1.3M vs. loss of $2.6M a year ago.
- Adjusted EBITDA of $2.0M vs. loss of $1.7M; margin improved to 49.7% from 38.8%.
- Total costs and expenses fell 15.8% to $12.7M; cash $2.9M with zero debt.
- CEO cites cost cuts and leaner operations; expects some volatility but sustained EBITDA profitability.
- Conference call scheduled for Sept. 11 at 4:30 p.m. EDT.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828024040137/0001628280-24-040137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828024040137/csbr-20240911.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-040137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer